External defibrillators and implantable cardioverter defibrillators (ICDs) are the two products in the North American defibrillators market. The ICD category is further bifurcated into transvenous implantable cardioverter defibrillators (T-ICDs) and subcutaneous implantable cardioverter defibrillators (S-ICDs). Among these two, T-ICD is expected to be the faster growing category in this market, advancing at a CAGR of 4.3% during the forecast period.
Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/north-america-defibrillators-market
The report further classifies the North American T-ICDs market into CRT-Ds, dual-chamber ICDs, and single-chamber ICDs. The market for CRT-Ds is expected to generate $2.0 billion revenue by 2023, mainly on account of the increasing demand for CRT-Ds for the treatment of advanced heart failure.
Among the various external defibrillators available in the North American defibrillators market, automated external defibrillator (AED) is expected to lead the market, in terms of size as well as growth, in the coming years. This category is expected to grow at the fastest CAGR of 5.9% during the forecast period.
Request to Get the Sample Pages at: https://www.psmarketresearch.com/market-analysis/north-america-defibrillators-market/report-sample
Given the growing awareness about the life-saving potential of defibrillators in case of emergencies, the installation of these devices is increasing in public places such as train stations, schools and colleges, shopping centers, airports, malls, and leisure centers. These defibrillators are also known as public access defibrillators (PADs), as they can be used by anyone during an emergency.
Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=north-america-defibrillators-market
The report also provides insights into regulatory scenario, pricing analysis of various types of defibrillators available in the North American market, and reimbursement polices related to these products.
The key players in the North American defibrillators market are Koninklijke Philips N.V., Abbott Laboratories, Boston Scientific Corporation, Stryker Corporation, Medtronic plc, BIOTRONIK SE & Co. KG, SCHILLER AG, Asahi Kasei Corporation, Defibtech LLC and Cardiac Science Corporation.